Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
about
Opioid agonist treatment for pharmaceutical opioid dependent peopleMethadone at tapered doses for the management of opioid withdrawalOral substitution treatment of injecting opioid users for prevention of HIV infectionMethadone maintenance therapy versus no opioid replacement therapy for opioid dependenceSubstitution treatment of injecting opioid users for prevention of HIV infectionMethadone at tapered doses for the management of opioid withdrawalDihydrocodeine for detoxification and maintenance treatment in illicit opiate-dependent individualsOpioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaDrug dependence, parenting responsibilities, and treatment history: why doesn't mom go for help?A therapeutic workplace for the long-term treatment of drug addiction and unemployment: eight-year outcomes of a social business interventionStructural-level factors affecting implementation of the methadone maintenance therapy program in China.A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.New methods of treatment efficacy research: bridging clinical research and clinical practice.Buprenorphine treatment in an urban community health center: what to expectPsychometric properties of the Chinese craving beliefs questionnaire for heroin abusers in methadone treatment.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Problems for clinical judgement: 5. Principles of influence in medical practiceReport of the Council on Scientific Affairs: methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse.Alcohol use and gender effects on HIV risk behaviors in cocaine-using methadone patientsBringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practiceDeep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.Methadone treatment providers' views of drug court policy and practice: a case study of New York StateStandard magnitude prize reinforcers can be as efficacious as larger magnitude reinforcers in cocaine-dependent methadone patients.Opportunities to diagnose, treat, and prevent HIV in the criminal justice system.Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapyThe impact of financial discharge from methadone maintenance therapy on incarcerationOpioid dependence treatment, including buprenorphine/naloxone.The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.Characteristics and 9-month outcomes of discharged methadone maintenance clients.Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.Methadone medical maintenance in primary care. An implementation evaluation.Improving psychosocial health and employment outcomes for individuals receiving methadone treatment: a realist synthesis of what makes interventions work.Policy progress for physician treatment of opiate addiction.Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern TaiwanNarcotic-induced hypogonadism during therapy for heroin addiction.Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatmentCommentary on Burns et al. (2015): retention in buprenorphine treatmentSupply of buprenorphine waivered physicians: the influence of state policies.
P2860
Q24185775-86FE47D5-7DA5-4907-A16F-0BC5D31C5AEBQ24200729-6DD4E5BF-C562-4B2A-8029-1978A06F87A4Q24234956-BF5082B6-4605-46BA-99EB-E830F51EC2F0Q24239965-8C1D1AAD-A412-48A0-952F-7A1DD803934CQ24243272-8345CB58-146D-4DAF-87D2-7073C2C2F5B3Q24246574-F5BA5010-51E6-492D-9EA4-239398F00A8EQ26471618-00B07C3E-8CD3-42EB-BE57-60EFC8E0E0CDQ26778626-23366277-674F-48DE-AD0F-90651BB4D643Q28344318-60AD7635-4D6A-4DE3-8530-E85A27B33FBFQ28655452-30B5FD15-31EF-450C-8085-8E80F2817844Q33624370-98914E03-763A-4B94-8962-0A3574B472EAQ33651514-18592047-594C-4DFF-874B-4BCB8F30B21AQ33669425-9947B829-5C43-4BD7-B56F-D5B119B4A916Q33735289-78BD15BA-EDBB-4CC3-A6DE-14913BAA649FQ33841448-AD56B608-549B-4ABF-B050-D291A927255AQ33870389-58C55A62-8CA5-4B91-AA4D-B17808798514Q33870799-30CE16CE-A4BD-4DFA-852D-B31A01D13B9AQ33943801-FE859E2E-96F7-4889-BF57-4D55404E16D3Q34051233-42EBBDA7-3894-4F9F-B0B1-136EE3165EC3Q34081656-592D4A4A-931B-461B-B569-5F85E65B20A9Q34113771-B424F705-81CC-4259-AFD4-05B8E18C41F8Q34216585-8CB7DD68-A89D-45EA-8B47-DA82EBA21D68Q34250149-7F5FBC5D-8203-4A86-A3AE-3B70E83F9BEEQ34437363-760EEF03-1796-4CB9-9198-90B65A559619Q34472876-24D81AC5-A623-44DA-A0D8-8912F6F75633Q34481998-D094F2A8-B367-45DD-A730-991D9B802711Q34527971-E85F7033-00B3-421B-8AFC-8CF99FDA077AQ34533873-1F282CB6-EE29-4CC5-8A56-9DD6E993AEB6Q34620483-F5BB56AA-0379-4080-908A-C7ACFFCE5AEFQ34674269-45546A32-61BA-4752-90F8-6FD45E7C4696Q34704122-7428799A-47DE-4DB3-9AA0-14579B2F079BQ34722914-E94D7F55-5113-43B9-991A-B850F23A5C30Q34728976-0B0C62AB-1261-41D7-84E9-AB8D6CB79142Q34743036-15076F1B-3186-4C11-879C-C44318429955Q34818254-5B88C07E-2144-49D6-B9AF-04693D502663Q34893324-4CD55B59-183C-48F0-8561-21E7853C8B0AQ35023989-5BCBAFA5-58D2-427F-9D97-301634BA5EBAQ35074748-2587D6A1-10B9-4D46-A1D1-87524859C8E3Q35198995-DBFBB794-0FBE-47A6-B910-E54E40C4332BQ35571613-3CE2A6CB-D63F-42F4-BD2B-0D5046200578
P2860
Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Methadone maintenance vs 180-d ...... a randomized controlled trial.
@en
type
label
Methadone maintenance vs 180-d ...... a randomized controlled trial.
@en
prefLabel
Methadone maintenance vs 180-d ...... a randomized controlled trial.
@en
P2093
P356
P1476
Methadone maintenance vs 180-d ...... a randomized controlled trial.
@en
P2093
H Robillard
K L Delucchi
P304
P356
10.1001/JAMA.283.10.1303
P407
P577
2000-03-01T00:00:00Z